MARK KUCZMANSKI: Open Payments
NPI 1346432333 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,029 in 80 payments from 8 companies in 2025. Trend: 2023 $504 · 2024 $453 · 2025 $1,029
Food & beverage: $945Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $314 |
| Janssen Biotech, Inc. | 20 | $273 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 29 | $252 |
| Phathom Pharmaceuticals, Inc. | 2 | $67 |
| PFIZER INC. | 3 | $50 |
| Novo Nordisk Inc | 2 | $34 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Celltrion USA Inc. | 1 | $15 |
Products named: RINVOQ, TREMFYA, XIFAXAN, VOQUEZNA, RELISTOR, VELSIPITY, Wegovy, VOWST.
Industry payments across NY — which companies pay providers there.
